Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTISS for prevention of latissimus dorsi donor-site seroma after immediate breast reconstruction
NL-OMON41295Recruiting
- Sponsor
- Isala
- Start
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, single-blind trial of porcine fibrin sealant in Seroma (2 arms), sponsored by Isala. Primary endpoints: Total volume of donor-site seroma, Seroma incidence after drain removal and 1 more. Started Jul 2015; status: recruiting.
02
Drugs
porcine fibrin sealant
03
Conditions
Seroma
Beyond the preview
Go deeper on NL-OMON41295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41295.